Medically equal to IV chelation, now there's no worries about traveling long distances to sit for hours at a time, hooked up to an IV at a doctors office. Detoxamin...it's about time.
EDTA (Ethylene diamine tetra acetic acid), the active ingredient in Detoxamin, is a synthetic amino acid that has the ability to attach itself to metals and minerals, forming a particular kind of bond called a chelate. Heavier metals have a greater affinity for the EDTA and form stronger bonds. Early in its history, in the 40's and 50's, EDTA was found to be an effective treatment for lead toxicity and was approved by the FDA as a safe drug for that purpose. In many cases, patients who coincidentally had symptoms of heart disease, such as angina, improved while undergoing the lead toxicity treatment. Since that time, a number of studies have confirmed the effectiveness of chelation therapy for blood vessel disease, including improved blood flow to the heart, the legs and the brain. Experienced physicians and medical researchers have published them in reputable journals.
The exact action of EDTA in improving blood vessel disease is not clear, and it probably works by several mechanisms.
Chelation comes from the Greek word "claw," meaning "to grab," which is exactly what EDTA does. When a molecule of EDTA travels through the bloodstream and gets near a toxic metal such as lead or mercury, it grabs the destructive particle and binds tightly with it, pulling it out of the membrane or body tissue it was embedded in.
Since EDTA is an artificial amino acid, and since the body regards it as a foreign substance, the body eliminates the entire particle-the heavy particle coated with EDTA. The body can't tell that underneath the coating is some harmful material that it might be willing to keep even though it is harmful. Ultimately, both the EDTA and the toxic substance are delivered to the kidneys, which excrete them in the urine.
Detoxamin's facility is registered with the United States Food and Drug Administration and manufactures Detoxamin under the supervision of expert Ph.D.s in chemistry and nutrition. Additionally, our processes strictly follow Good Manufacturing Practices (GMPs). All ingredients are of the highest USP grade, with assays certifying potency and purity. Our state-of-the-art scientific quality-control testing laboratory ensures that you receive the highest quality products available. Detoxamin is very affordable, with substantial health benefits it provides and is more affordable to those who have difficulty with the higher priced IV route of administration.
Medically equal to the I.V. method of EDTA chelation, which is the gold standard of removing toxic metals.
Detoxamin EDTA Suppositories proven in published research, utilises the power of Ca-EDTA, having the longest track record for safety and effectiveness. With scientific proof of bioavailability & absorption superior to even that of IV chelation.
Easy To Do
Detoxamin is also far safer than IV chelation because the EDTA in the Detoxamin travels through the body at a much slower rate, which alleviates an undue elimination burden on the liver and kidneys. Discover the power of Detoxamin.
Today we have to cope with an ever-increasing load of toxins in this industrial 21st century. They include air pollutants and heavy metal contaminants. However, nearly 100 years of evidence shows that EDTA chelation can effectively address our modern heavy metal issues. Free radicals produced in the cell itself comprise only a fraction of the "oxidative stress" load with which the cell must cope. Other sources of free radicals include air pollutants and exposure to heavy metal contaminants. These renegade molecules oxidize or burn holes in the cell membranes and this action can lead to cell death. If only we would be as concerned about free radicals and their impact on the membranes of our cells as we are about putting on sunscreen to protect our skin! The action is similar and it's just as important to our health.
EDTA has been proven to protect cell membranes, DNA and enzyme systems by reducing the destructive effects of free radicals.
Free radicals are reactive molecules that are unstable because they are missing an electron. In an effort to replace their lost electron, they frantically bump into and damage the molecules that make up the cells in your body. In the process, they cause oxidation of body tissues.
It's impossible to be alive and not have some oxidative damage, because free radicals are produced by normal processes in the body, such as the production of energy and immune function. Free radicals also come from environmental sources including heavy metals, household chemicals, ultraviolet radiation, tobacco smoke, food additives, foods that have been fried in oil that's been used over and over again (typical in many fast-food restaurants), and other pollutants. Once free radicals are released, they will multiply exponentially in chain reactions, unless they are stopped by antioxidants.
When a free radical comes in contact with the inner lining of your arteries, microscopic injuries result. This process is called lipid peroxidation (the process that causes fats to become rancid) and is recognized as one of the underlying causes of atherosclerosis. Eventually the build-up of fat, cholesterol, toxic metals and other substances at the site of injury narrows the arteries. The key is to neutralize free radicals before they damage your arteries … and that's done with antioxidants.
Antioxidants are the vitamins, minerals, enzymes, or other chemical compounds- such as EDTA-that give up an electron to stop the production of free radicals. And EDTA actually reduces free radicals even before they have a chance to get started. Here's how: When metals, minerals and other toxins are in the body, they act as the catalyst for oxidation reactions, including lipid peroxidation. This triggers the production of free radicals.
But when EDTA is in the blood, it removes the metals and minerals before they get a chance to catalyze, or start the oxidation reactions. The result? The production of free radicals is dramatically reduced and their destructive influence is prevented - which means DNA and cells stay healthy - so YOU stay healthier and live longer!
Our bodies continuously struggle to get rid of the chemicals we ingest through water, food and air. Many of the chemicals we're exposed to on a daily basis didn't exist twenty-five years ago. Even vaccines routinely contain a preservative called Thimerosal, which is made up, in part, from mercury. Hard to believe- but the average six-month-old infant has already been exposed to his/her lifetime EPA quota of me.
"Human exposure to heavy metals has risen dramatically in the last 50 years as a result of an exponential increase in the use of heavy metals in industrial processes and products," says Maile Pouls, Ph.D (Townsend Letter for Doctors and Patients, July 1999). In addition to the chemical hazards at home and outdoors, many occupations involve daily, heavy metal exposure.
More than 50 professions entail exposure to mercury alone. If you are a physician, pharmaceutical worker, laboratory worker, hairdresser, painter, printer, welder, metalworker, cosmetic worker, battery maker, engraver, photographer, visual artist, potter or involved in any dental occupation, you are exposed to heavy metals on a daily basis.
But lead toxicity has been around for a long time. Greek physicians gave a clinical description of lead poisoning in 100 BC. US medical authorities diagnosed childhood lead poisoning in 1887. Leaded gasoline went on sale in select markets in 1923. And in 1932, the British Medical Journal cited lead poisoning as "slow, subtle insidious saturation of the system by infinitesimal doses of lead extending over a long period of time."
Dr. Claire Patterson of the California Institute of Technology did a study in 1965 called "Contaminated and Natural Lead Environments of Man," which offered first hand proof that high lead levels in industrial nations are man-made and endemic. In fact, the study showed that the average bone lead level of a deceased person today averages approximately 1000 times higher than that of deceased people who lived 400-500 years ago.
Symptoms of heavy metal exposure can include a wide range of problems from neurological disorders, such as Parkinson's disease and Multiple Sclerosis, to attention deficit disorders and learning disabilities … to excessive free radical production and dangerous blockages in the arteries, which lead to cardiovascular disease. Even the rise in fatigue disorders, cancers and autoimmune diseases could be related to a toxic burden of heavy metals in the body.
REFERENCES:
1. CaEDTA Suppositories to Treat Elevated Blood Lead Levels in Children by Ted Rozema, MD
2. Benefits of EDTA Chelation Therapy in Arteriosclerosis a Retrospective Study of 470 Patients by C. Hancke, MD, and K. Flytlie, MD
3. A Pilot Double Blind Study of Sodium Magnesium EDTA in Peripherral Vascular Disease by Efrain Olszewer, MD, Fuad Calil Sabbag, MD, and James P. Carter, MD, DrPH New Orleans, Louisiana
4. EDTA Chelation Therapy Efficacy in Arteriosclerotic Heart Disease by H. Richard Casdorph, MD, PhD
5. EDTA Chelation Therapy III Treatment of Peripheral Arterial Occlusion an Alternative to Amputation by H. Richard Casdorph, MD, PhD and Charles H. Farr, MD, PhD
6. EDTA Chelation Therapy in Chronic Degenerative Disease by EFRAIN OLSZEWER and JAMES P. CARTER
7. The Correlation Between EDTA Chelation Therapy and Improvement in Cardiovascular Function A Meta Analysis by L. Terry Chappell, MD, and John P. Stahl, PhD
8. 6 Children with Lead Poisoning by John A, Friedman, MD, Howard L. Weinberger, MD
9. A Nonsurgical Approach to Obstructive Carotid Stenosis Using EDTA Chelation by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and R.K. Barber, BS, ACSM, ETT
10. Absorbtion of Drugs from the Rat Colon by Lewis S. Schanker by Lewis S. Schanker
11. An Observation of the Effect of EDTA Chelation and Supportive Multivitamin Trace Mineral Supplementation onBlood Platelet Volume a Brief Communication by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and R.K. Barber, BS, ACSM, ETT
12. An Oculocerebrovasculometric Analysis of the Improvement in Arterial Stenosis Following EDTA Chelation Therapy by E.W. McDonagh, DO, FACGP, C.J. Rudolph, DO, PhD, E. Cheraskin, MD, DMD
13. Beneficial Effects of Zinc Supplementation During Chelation Treatment of Lead Intoxication in Rats by S.J.S. Flora and S.K. Tandon
14. Carotid Restenosis a Case for EDTA Chelation by H. Joseph Holliday, MD, FACA, RVT
15. Chelation Therapy a Survey of Treatment Outcomes and Selected SocioMedical Factors by Wesley J. Adams, PhD, and Charles T. McGee, MD
16. Chelation Therapy of Occlusive Arteriosclerosis in Diabetic Patients by Carlos P. Lamar, MD, F.I.C.A.
17. Chronic Diseases A Practical Method for the Reduction of Plasma Cholesterol in Man by Henry A. Schroeder, M.D.
18. Current Status of EDTA Chelation Therapy in Occlusive Arterial Disease by Elmer M. Cranton, MD, James P. Frackelton, MD
19. Demographic Data and Treatment of Small Companion Animals With Lead Poisoning 347 Cases 1977 to 1986 by Rhea V. Morgan, DVM; Laurie K. Pearce, DVM; Frances M. Moore, DVM; Thomas Rossi, DVM, MS
20. Disappearance of Immune Deposits with EDTA Chelation Therapy in a Case of IgA Nephropathy by Ja-Liang Lin, MD
21. Disintergration of Retroviruses by Chelating Agents by V. Wunderlich and G. Sydow
22. EDTA Chelation Treatment for Vascular Disease A Meta Analysis Using Unpublished Data by L. Terry Chappell, MD, John P. Stahl, PhD, and Ronald Evans, MA
23. Effect of EDTA Chelation and Supportive Multivitamin Trace Mineral Supplementation Chronic Lung Disorders A Study of FVC and FEV by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and Rhonda.K. Barber, BS, ACSM, ETT
24. Effect of EDTA Chelation and Supportive Multivitamin Trace Mineral Supplementation on Carotid Circulation Case Report by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP
25. Effect of EDTA Chelation Therrapy Plus Multivitamintrace Mineral Supplementation Upon Vascular Dynamics Ankle Brachial Doppler Systolic Blood Pressure Ratio by E.W. McDonagh, DO, C.J. Rudolph, DO, E Cheaskin, MD, DMD
26. Elevated Lead Levels in a Patient with Sickle Cell Disease and Inappropriate Secretion of Antidiuretic Hormone by Carlos R. Suarez, MD, Lehman E. Black III, MD, R. Morrison Hurley, MD
27. Lead Nephropathy Gout and Hypertension by Vicihi Batuman, MD, FACP
28. Lead Toxicity Chelation Therapy New Findings by R. Gooneratne and A. Olkowski
29. Magnetic Resonance Imaging Evidence of a Reduction in Disc Herniation Using a Combination of EDTA Chelation and Joint Reconstructive Therapy by C.J. Rudolph, DO, PhD, FACAM, E.W. McDonagh, DO, ACGP, FACAM
30. Mineral Excretion Associated with EDTA Chelation Therapy by Hugh D. Riordan, M.D., Emanuel Cheraskin, M.D., D.M.D., and Marvin Dirks, B.D., M.A.
31. Visual Field Evidence of Macular Degeneration Reversal Using a Combination of EDTA Chelation and Multiple Vitamin and Trace Mineral Therapy by C.J. Rudolph, DO, PhD, FACAM, R.T. Samuels, OD, and E.W. McDonagh, DO, ACGP, FACAM
32. Oral calcium EDTA in lead intoxication of children by J. Edmund Bradley, M.D., and Albert M. Powell, Jr., M.D.
33. Potential Uses of Chelation Methods in the Treatment of Cardiovascular Diseases by J. Roderick Kitchell, Lawrence E. Meltzer and Marvin J. Seven
34. Reduction of Elevated Plasma Lipid Levels in Artherosclerosis following EDTA Therapy by J. H. Olwin and J. L. Koppel
35. Safety Evalutation Studies of Calcium EDTA by Bernard L. Oser, Mona Oser and Howard C. Spencer
36. The "Clinical Change" in Patients Treated with EDTA Chelation Plus Multivitamin/Trace Mineral Supplementation by Edward W. McDonagh, D.O., Charles J. Rudolph, Ph.D., D.O., and Emanuel Cheaskin, M.D., D.M.D.
37. The Correlation Between EDTA Chelation Therapy and Improvement in Cardiovascular Function: A Meta-Analysis by L. Terry Chappell, MD, and John P. Stahl, PhD
38. The Current Status of EDTA Chelation Therapy by Elmer M. Cranton, MD
39. The Effect of Calcium Chelation on Cardiac Arrythmias and Conduction Disturbances by Sidney Jick, M.D. and Robert Karsh, M.D.
40. The Effect of EDTA Chelation Therapy Plus Supportive Multivitamin Trace Mineral Supplementation Upon Renal Function: A Study in Blood Urea Nitrogen (BUN) by E.W. McDonagh, DO, C.J. Rudolph, DO, PhD, E. Cheraskin, MD, DMD
41. The Effect of EDTA Chelation Therapy Plus Supportive Multivitamin Trace Mineral Supplementation Upon Renal Function: A Study in Serum Creatinine by EW McDonagh, DO, CJ Rudolph, PhD, DO, E Cheraskin, MD, DMD
42. The Effects of Thiamin on Lead Metabolism: Whole Body Retention of Lead-203 by Jin Suk Kim, Donald L. Hamilton, Barry R, Blakley, and Colin G. Rousseaux
43. The Efficacy of Chelation Therapy and Factors Influencing Mortality in Lead Intoxicated Petrol Sniffers by C. B. Burns PhD, B. Currie
44. Treatment of Occlusive Vascular Disease with Disodium Ethylene Diamine Tetraacetic Acid (EDTA) by Norman E. Clarke, Sr. M.D., Norman E. Clarke Jr. M.D. and Robert E. Mosher, PhD
45. Proof of EDTA's Permeability by way of the Colon by M. Ella, R Behrens, C Northrop, P Wraight and G. Neale Dunn Clinical Nutrition Centre and New Addenbrooke's Hospital, Cambridge, U.K.